Turn Therapeutics Inc. Common Stock (TTRX) — Tangible Net Worth Ratio
Turn Therapeutics Inc. Common Stock (TTRX) has a Tangible Net Worth Ratio of 85.0% as of March 2026. This metric is calculated by deducting intangible assets ($919.95K) from net assets ($6.12 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check Turn Therapeutics Inc. Common Stock earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Turn Therapeutics Inc. Common Stock Tangible Net Worth Ratio (2023–2025)
This chart shows how Turn Therapeutics Inc. Common Stock's Tangible Net Worth Ratio has changed across 2 annual periods from 2023 to 2025. As of March 2026, the ratio stands at 85.0%, reflecting net assets of $6.12 Million with intangible assets of $919.95K USD. See Turn Therapeutics Inc. Common Stock book value and equity for net asset value and shareholders' equity analysis.
Annual Tangible Net Worth Ratio for Turn Therapeutics Inc. Common Stock (2023–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Turn Therapeutics Inc. Common Stock from 2023 to 2025, covering 2 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see TTRX market cap overview.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 80.3% | $4.69 Million | $922.17K | $12.16 Million | ▲ +878.0 pp |
| 2023 | -797.7% | $85.77K | $769.94K | $2.01 Million | — |